Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 411

1.

DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 study.

Miyazaki K, Asano N, Yamada T, Miyawaki K, Sakai R, Igarashi T, Nishikori M, Ohata K, Sunami K, Yoshida I, Yamamoto G, Takahashi N, Okamoto M, Yano H, Nishimura Y, Tamaru S, Nishikawa M, Izutsu K, Kinoshita T, Suzumiya J, Ohshima K, Kato K, Katayama N, Yamaguchi M; CD5+ DLBCL Treatment Study Group.

Haematologica. 2019 Oct 24. pii: haematol.2019.231076. doi: 10.3324/haematol.2019.231076. [Epub ahead of print]

2.

Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon-based therapy.

Kawaguchi T, Ide T, Kondo R, Nomura Y, Arinaga-Hino T, Kuwahara R, Amano K, Sano T, Akiba J, Ohshima K, Yano H, Torimura T.

Exp Ther Med. 2019 Nov;18(5):3991-4001. doi: 10.3892/etm.2019.8024. Epub 2019 Sep 18.

3.

Cutaneous Histiocytic Sarcoma With Cellular Cannibalism.

Nanri A, Katayama E, Imamura T, Muto I, Saruta H, Akiba J, Ohshima K, Nakama T, Ohata C.

Am J Dermatopathol. 2019 Sep 19. doi: 10.1097/DAD.0000000000001525. [Epub ahead of print]

PMID:
31567137
4.

The expression of cell adhesion molecule 1 and its splicing variants in S├ęzary cells and cell lines from cutaneous T-cell lymphoma.

Yamaguchi M, Morizane S, Hamada T, Miyake T, Sugaya M, Iwata H, Fujii K, Haramoto-Shiratsuki R, Nakagawa Y, Miura M, Ohshima K, Morishita K, Takahashi T, Imada M, Okada K, Uehara J, Sowa-Osako J, Iwatsuki K.

J Dermatol. 2019 Nov;46(11):967-977. doi: 10.1111/1346-8138.15078. Epub 2019 Sep 12.

PMID:
31515833
5.

[Clinical features of adult-onset chronic active Epstein-Barr virus infection].

Kawamoto K, Miyoshi H, Seto M, Kimura H, Ohshima K.

Rinsho Ketsueki. 2019;60(8):944-952. doi: 10.11406/rinketsu.60.944. Japanese.

PMID:
31484894
6.

[BCL2, BCL6, and MYC-positive intravascular large B-cell lymphoma presenting with bilateral adrenal gland lesions].

Ogasawara T, Ebata N, Hamasaki J, Marshall S, Kawauchi K, Ohshima K, Mori N, Sakura H.

Rinsho Ketsueki. 2019;60(6):570-576. doi: 10.11406/rinketsu.60.570. Japanese.

PMID:
31281146
7.

Sarcomatoid Variant of Primary Cutaneous Anaplastic Large Cell Lymphoma.

Natsuaki Y, Muto I, Kawamura M, Saruta H, Teye K, Ohshima K, Nakama T, Ohata C.

Am J Dermatopathol. 2019 Dec;41(12):e164-e167. doi: 10.1097/DAD.0000000000001483.

PMID:
31268929
8.

Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities In Vitro and In Vivo.

Ma G, Yasunaga JI, Ohshima K, Matsumoto T, Matsuoka M.

J Virol. 2019 Jul 30;93(16). pii: e00413-19. doi: 10.1128/JVI.00413-19. Print 2019 Aug 15.

PMID:
31167921
9.

Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.

Morishige S, Nishi M, Saruta H, Arakawa F, Yamasaki Y, Oya S, Nakamura T, Seki R, Yamaguchi M, Aoyama K, Mouri F, Osaki K, Ohshima K, Nagafuji K.

Int J Hematol. 2019 Oct;110(4):506-511. doi: 10.1007/s12185-019-02675-1. Epub 2019 May 31.

PMID:
31152415
10.

Methotrexate-associated Lymphoproliferative Disorders in Patients With Rheumatoid Arthritis: Clinicopathologic Features and Prognostic Factors.

Kurita D, Miyoshi H, Ichikawa A, Kato K, Imaizumi Y, Seki R, Sato K, Sasaki Y, Kawamoto K, Shimono J, Yamada K, Muto R, Kizaki M, Nagafuji K, Tamaru JI, Tokuhira M, Ohshima K.

Am J Surg Pathol. 2019 Jul;43(7):869-884. doi: 10.1097/PAS.0000000000001271.

PMID:
31116708
11.

Transformation of follicular lymphoma to double-hit lymphoma during adjuvant chemotherapy for concurrent ovarian carcinoma.

Narazaki T, Nakashima Y, Tsukamoto Y, Tsuda M, Masuda T, Kimura D, Takamatsu A, Ohshima K, Shiratsuchi M, Ogawa Y.

Int J Hematol. 2019 Sep;110(3):375-380. doi: 10.1007/s12185-019-02656-4. Epub 2019 May 18.

PMID:
31104212
12.

Molecular heterogeneity in peripheral T-cell lymphoma, not otherwise specified revealed by comprehensive genetic profiling.

Watatani Y, Sato Y, Miyoshi H, Sakamoto K, Nishida K, Gion Y, Nagata Y, Shiraishi Y, Chiba K, Tanaka H, Zhao L, Ochi Y, Takeuchi Y, Takeda J, Ueno H, Kogure Y, Shiozawa Y, Kakiuchi N, Yoshizato T, Nakagawa MM, Nanya Y, Yoshida K, Makishima H, Sanada M, Sakata-Yanagimoto M, Chiba S, Matsuoka R, Noguchi M, Hiramoto N, Ishikawa T, Kitagawa J, Nakamura N, Tsurumi H, Miyazaki T, Kito Y, Miyano S, Shimoda K, Takeuchi K, Ohshima K, Yoshino T, Ogawa S, Kataoka K.

Leukemia. 2019 Dec;33(12):2867-2883. doi: 10.1038/s41375-019-0473-1. Epub 2019 May 15.

PMID:
31092896
13.

[Heterogeneity of genomic alterations and clinical aspects in peripheral T-cell lymphoma: future perspectives].

Yoshida N, Seto M, Ohshima K.

Rinsho Ketsueki. 2019;60(4):271-280. doi: 10.11406/rinketsu.60.271. Japanese.

PMID:
31068555
14.

[Enteropathy-associated T-cell lymphoma coexisting with composite lymphoma composed of DLBCL and PTCL].

Imanishi D, Hata T, Imaizumi Y, Niino D, Ohshima K, Miyazaki Y.

Rinsho Ketsueki. 2019;60(3):197-202. doi: 10.11406/rinketsu.60.197. Japanese.

PMID:
31068515
15.

Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with MYC locus rearrangement.

Kato T, Itonaga H, Taguchi J, Makiyama J, Fujioka M, Taguchi M, Horai M, Sawayama Y, Niino D, Imaizumi Y, Hata T, Yoshida S, Sakamoto K, Takeuchi K, Ohshima K, Miyazaki Y.

Leuk Res Rep. 2019 Apr 22;11:31-33. doi: 10.1016/j.lrr.2019.04.005. eCollection 2019.

16.

Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.

Sakamoto H, Itonaga H, Taguchi J, Kato T, Sawayama Y, Hayashi T, Baba S, Moriuchi M, Ohshima K, Yoshida S, Moriuchi Y, Miyazaki Y.

Leuk Res Rep. 2019 Apr 22;11:27-30. doi: 10.1016/j.lrr.2019.04.003. eCollection 2019.

17.

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018).

Kawano N, Yoshida N, Kawano S, Arakawa F, Miyoshi H, Yamada K, Nakashima K, Yoshida S, Kuriyama T, Tochigi T, Nakaike T, Shimokawa T, Yamashita K, Marutsuka K, Mashiba K, Kikuchi I, Ohshima K.

Intern Med. 2019 Aug 1;58(15):2159-2166. doi: 10.2169/internalmedicine.2513-18. Epub 2019 Apr 17.

18.

Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.

Komaki S, Sugita Y, Furuta T, Yamada K, Moritsubo M, Abe H, Akiba J, Miyagi N, Nakamura H, Miyoshi H, Ohshima K, Morioka M.

J Neuropathol Exp Neurol. 2019 May 1;78(5):389-397. doi: 10.1093/jnen/nly124.

19.

Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases.

Satou A, Tabata T, Miyoshi H, Kohno K, Suzuki Y, Yamashita D, Shimada K, Kawasaki T, Sato Y, Yoshino T, Ohshima K, Takahara T, Tsuzuki T, Nakamura S.

Mod Pathol. 2019 Jul;32(8):1135-1146. doi: 10.1038/s41379-019-0264-2. Epub 2019 Apr 5.

PMID:
30952973
20.

Primary Chest Wall MYC/BCL6 Double-hit Lymphoma with t (3;7) (q27;p12) and t (8;14) (q24;q32) Translocations.

Kamachi K, Kubota Y, Nagaie T, Yamaguchi K, Ogusu S, Kidoguchi K, Kusaba K, Kizuka-Sano H, Nishioka A, Yoshimura M, Yokoo M, Ando T, Kai K, Kojima K, Ohshima K, Sueoka E, Kimura S.

Intern Med. 2019 Jul 15;58(14):2073-2077. doi: 10.2169/internalmedicine.2532-18. Epub 2019 Mar 28.

Supplemental Content

Loading ...
Support Center